A new publication regarding peptide research connected to LL-37 appeared on September 29, 2026. The publication, titled "RK-14: A Novel Antimicrobial Peptide Targeting Multidrug-Resistant Bacteria and Catheter-Associated Biofilms," was published in Probiotics and Antimicrobial Proteins.
This entry is listed as a new publication record under the identifier 42809173. The title indicates the paper addresses antimicrobial peptide activity against multidrug-resistant bacteria and catheter-associated biofilms. No findings, results, or conclusions from the paper are included in this brief beyond the title and publication details provided.
LL-37 remains classified as an unapproved compound used in research settings. This brief does not characterize the paper's data, efficacy claims, or safety implications, as that information was not provided alongside the publication record. Readers interested in the full scope of the study should consult the original source directly for methodology and results.
For additional background on this compound and its research status, readers can refer to the compound overview.